Astrazeneca PLC AZN is expected to report its Q2 EPS at $1.80 on revenue of $8.19 billion.
Exxon Mobil Corporation XOM is projected to report its Q2 EPS at $2.33 on revenue of $121.39 billion.
Bristol-Myers Squibb Company BMY is estimated to report its Q2 EPS at $0.55 on revenue of $5.04 billion.
Time Warner Cable Inc TWC is expected to report its Q2 EPS at $1.16 on revenue of $4.94 billion.
Kellogg Company K is projected to report its Q2 EPS at $0.91 on revenue of $3.29 billion.
Goodyear Tire & Rubber Company GT is projected to report its Q2 EPS at $0.27 on revenue of $5.18 billion.
Sprint Nextel Corporation S is estimated to post a Q2 loss at $0.12 per share on revenue of $8.30 billion.
Starbucks Corporation SBUX is projected to report its Q3 EPS at $0.34 on revenue of $2.85 billion.
EI DuPont de Nemours & Co DD is expected to report its Q2 EPS at $1.34 on revenue of $9.86 billion.
Motorola Mobility Holdings Inc MMI is estimated to post its Q2 EPS at $0.06 on revenue of $3.12 billion.
Colgate-Palmolive Company CL is projected to report its Q2 EPS at $1.25 on revenue of $4.17 billion.
International Paper Co IP is projected to report its Q2 EPS at $0.67 on revenue of $6.63 billion.
Starwood Hotels & Resorts Worldwide Inc HOT is projected to report its Q2 earnings at $0.46 per share on revenue of $1.41 billion.
Tyco International Ltd TYC is expected to report its Q3 EPS at $0.73 on revenue of $4.21 billion.
Waste Management Inc WM is projected to report its Q2 EPS at $0.55 on revenue of $3.34 billion.
Build-A-Bear Workshop Inc BBW is estimated to post a Q2 loss at $0.30 per share on revenue of $78.77 million.
Cabela's Inc CAB is expected to report its Q2 EPS at $0.27 on revenue of $566.08 million.
McClatchy Company (The) MNI is projected to report its Q2 EPS at $0.05 on revenue of $315.20 million.
D.R. Horton Inc DHI is estimated to post its Q3 EPS at $0.06 on revenue of $987.25 million.
Ball Corporation BLL is projected to report its Q2 EPS at $0.86 on revenue of $2.42 billion.
Wright Medical Group Inc WMGI is expected to report its Q2 EPS at $0.17 on revenue of $132.28 million.
Boston Scientific Corporation BSX is estimated to report its Q2 EPS at $0.09 on revenue of $1.94 billion.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In:
EarningsNewsPre-Market OutlookMarketsBroadcasting & Cable TVConsumer DiscretionaryConsumer StaplesDiversified ChemicalsEarnings ScheduledEnergyHealth CareHealth Care EquipmentHomebuildingHotels, Resorts & Cruise LinesHousehold ProductsIndustrial ConglomeratesIndustrialsIntegrated Oil & GasMaterialsMetal & Glass ContainersPackaged Foods & MeatsPaper ProductsPharmaceuticalsPublishingRestaurantsSpecialty StoresTelecommunication ServicesTires & RubberWireless Telecommunication Services
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in